A U.S. federal court has temporarily blocked an overhaul of the Advisory Committee on Immunization Practices (ACIP), a key vaccine advisory body under the Centers for Disease Control and Prevention, creating uncertainty around upcoming immunization guidance for COVID-19 and other diseases.
The ruling halts efforts led by Robert F. Kennedy Jr. to replace members of the panel and nullifies actions taken by the reconstituted committee. As a result, the United States currently lacks a fully operational federal mechanism for issuing vaccine recommendations.
ACIP guidance plays a critical role in shaping national vaccination policy, including determining insurance coverage, pharmacy administration protocols, and the broader rollout of immunization campaigns. With the panel sidelined, updated recommendations for COVID-19, influenza, and respiratory syncytial virus (RSV) vaccines may face delays, potentially affecting access and reimbursement.
Health experts stress that vaccination programs remain in place, but the disruption complicates the process of issuing clear, timely guidance—particularly ahead of seasonal immunization drives.
Under existing policy, CDC guidance for the 2025–2026 period has already narrowed the approach to COVID-19 vaccination. It emphasizes shared clinical decision-making for individuals aged six months and older, with stronger recommendations for adults aged 65 and above and those at higher risk.
Meanwhile, the U.S. Food and Drug Administration has aligned upcoming COVID-19 vaccines with JN.1-lineage variants, particularly LP.8.1, as part of its updated formulation strategy.
The U.S. administration has filed an appeal against the court decision. The outcome is expected to determine whether previous CDC recommendations remain in force or if a restructured advisory panel resumes its role in guiding national vaccine policy.
Experts caution that prolonged uncertainty could complicate planning for fall vaccination campaigns, even as efforts continue to maintain public access to essential immunizations.
